Source link : https://www.newshealth.biz/health-news/fda-okays-new-rapid-acting-biosimilar-insulin-for-diabetes/
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for treating adults and children with diabetes. The approval “highlights our continued efforts to improve the efficiency of the biosimilar approval process to help support a competitive marketplace and increase options for costly treatments, like insulin. Increasing […]
Author : News Health
Publish date : 2025-02-18 05:49:18
Copyright for syndicated content belongs to the linked Source.